Enzo Biochem, Inc. (ENZ)
NYSE: ENZ · Real-Time Price · USD
1.130
0.00 (0.00%)
Nov 4, 2024, 4:00 PM EST - Market closed
Enzo Biochem Revenue
In the fiscal year ending July 31, 2024, Enzo Biochem had annual revenue of $31.91M with 2.72% growth.
Revenue (ttm)
$31.91M
Revenue Growth
+2.72%
P/S Ratio
1.80
Revenue / Employee
$167,932
Employees
190
Market Cap
59.04M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jul 31, 2024 | 31.91M | 846.00K | 2.72% |
Jul 31, 2023 | 31.06M | -1.58M | -4.85% |
Jul 31, 2022 | 32.64M | -85.09M | -72.27% |
Jul 31, 2021 | 117.73M | 41.71M | 54.87% |
Jul 31, 2020 | 76.02M | -5.15M | -6.34% |
Jul 31, 2019 | Pro | Pro | Pro |
Jul 31, 2018 | Pro | Pro | Pro |
Jul 31, 2017 | Pro | Pro | Pro |
Jul 31, 2016 | Pro | Pro | Pro |
Jul 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
P3 Health Partners | 1.40B |
Cryo-Cell International | 31.84M |
Kronos Bio | 8.41M |
Aligos Therapeutics | 7.97M |
Shattuck Labs | 4.12M |
Syros Pharmaceuticals | 387.00K |
ENZ News
- 6 days ago - Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend - GlobeNewsWire
- 2 months ago - Enzo Biochem to pay $4.5 mln for failing to safeguard patient data - Reuters
- 3 months ago - Enzo Biochem: Is This Time Finally Different? - Seeking Alpha
- 5 months ago - Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update - GlobeNewsWire
- 8 months ago - Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update - GlobeNewsWire
- 9 months ago - Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments - GlobeNewsWire
- 11 months ago - ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE - GlobeNewsWire
- 1 year ago - Steven J. Pully Appointed to Enzo Biochem's Board of Directors - GlobeNewsWire